I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Antisense oligonucleotide therapy corrects splicing in the ..:
Melita Kaltak
;
Petra de Bruijn
;
Davide Piccolo
...
http://www.sciencedirect.com/science/article/pii/S2162253123000409. , 2023
Link:
https://doi.org/10.1016/j.omtn.2023.02.020
RT Journal T1
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:40b153ac34224120aa4a8a2cd3c85817&Exemplar=1&LAN=DE A1 Melita Kaltak A1 Petra de Bruijn A1 Davide Piccolo A1 Sang-Eun Lee A1 Kalyan Dulla A1 Thomas Hoogenboezem A1 Wouter Beumer A1 Andrew R. Webster A1 Rob W.J. Collin A1 Michael E. Cheetham A1 Gerard Platenburg A1 Jim Swildens PB Elsevier YR 2023 K1 MT: Oligonucleotides: Therapies and Applications K1 RNA therapy K1 antisense oligonucleotides K1 Stargardt disease K1 splicing correction K1 retinal organoids K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S2162253123000409 LK http://dx.doi.org/https://doi.org/10.1016/j.omtn.2023.02.020 DO https://doi.org/10.1016/j.omtn.2023.02.020 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)